Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at…

Here are JPMorgan’s top drug stock picks into earnings

JPMorgan is eyeing a few drug manufacturers ahead of their earnings reports as investors continue to…

These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments

The lucrative market for weight loss drugs won’t stay a duopoly forever. With billions at stake,…

European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai

European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another…

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says

Weight loss drugs have drawn investor interest and shaken up other sectors in the past year…

Viking Therapeutics stock jumps nearly 30% after drugmaker moves weight loss injection to late-stage trial

Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped 28%…

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain…

Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills

Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting this…

Pfizer moves forward with once-daily version of weight loss pill after setbacks

Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward with…

Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says

Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee on…

Investors want proof AI will aid drug discovery. Evidence may come in the second half

As investors peer into the future to envision which industries are ripe to be reshaped and…

Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

Think a friend or colleague should be getting this newsletter? Share this link with them to…

FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and…

FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…

Newseum Global